Mature tertiary lymphoid structures support B cell-mediated antitumour immunity and are disrupted by neoadjuvant therapy in rectal cancer: a multicentre, retrospective study
This study was supported by grants from the Natural Science Foundation of Beijing (7242034), New Technologies and Businesses of the PLAGH (5156ZE1X).
Authors
- Na Tian (ORCID: https://orcid.org/0000-0001-9978-2740)
- Junhua Dong
- Bin Wu (ORCID: https://orcid.org/0000-0003-0413-6987)
- Qiang Yuan
- Junchao Bai
- Junfeng Du (ORCID: https://orcid.org/0000-0002-8482-4271)
- Gang Chen (ORCID: https://orcid.org/0000-0002-8385-5965)
- Ran An (ORCID: https://orcid.org/0000-0002-4849-0120)
- Yuan Lv (ORCID: https://orcid.org/0000-0003-3802-0966)
- Aijun Liu (ORCID: https://orcid.org/0000-0001-7103-138X)
- Weixuan Li (ORCID: https://orcid.org/0000-0002-0846-3750)
- Qianyu Wang (ORCID: https://orcid.org/0000-0001-7048-8847)
- Huiyun Cai
- Wentao Zhong (ORCID: https://orcid.org/0009-0007-3395-9524)
- Dong Xing (ORCID: https://orcid.org/0000-0002-3355-4902)
- Liang Sun (ORCID: https://orcid.org/0000-0003-1634-4716)
- Hongyan Zhu (ORCID: https://orcid.org/0000-0002-3395-2222)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Chinese PLA General Hospital (CN)
Publication Details
- Journal
- EBioMedicine
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.ebiom.2025.106030
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05